Cargando…

Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations

In patients with rheumatic diseases undergoing immunosuppressive treatment, hepatitis B virus reactivation (HBVr) has been long recognized as a major treatment-related adverse event with substantial morbidity and mortality. Because HBVr is easily preventable with appropriate screening and monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koutsianas, Christos, Thomas, Konstantinos, Vassilopoulos, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	When Rheumatology and Infectious Disease Come Together
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076579/ https://www.ncbi.nlm.nih.gov/pubmed/32206094 http://dx.doi.org/10.1177/1759720X20912646

Ejemplares similares

Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents
por: Fernandez-Gutierrez, Benjamin, et al.
Publicado: (2021)

JAK inhibitors and infections risk: focus on herpes zoster
por: Sunzini, Flavia, et al.
Publicado: (2020)

Factors associated with sepsis risk in immune-mediated inflammatory diseases receiving tumor necrosis factor inhibitors: a nationwide study
por: Chao, Wen-Cheng, et al.
Publicado: (2020)

Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors
por: Evangelatos, Gerasimos, et al.
Publicado: (2020)

Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review
por: Tsai, Y. C., et al.
Publicado: (2020)

Hidradenitis suppurativa: infection, autoimmunity, or both?
por: Constantinou, Costas A, et al.
Publicado: (2019)

A cross-sectional investigation into the association between Porphyromonas gingivalis and autoantibodies to citrullinated proteins in a German population
por: Oluwagbemigun, Kolade, et al.
Publicado: (2019)

Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score
por: Wu, Wanlong, et al.
Publicado: (2019)

For patients with rheumatic disease and hepatitis C infection: the end of interferon
por: Calabrese, Leonard H, et al.
Publicado: (2015)

Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review
por: Luttropp, Karin, et al.
Publicado: (2019)

Impact of Rheumatic Diseases on Oral Health-Related Quality of Life
por: Aloyouny, Ashwag Y, et al.
Publicado: (2022)

The Fragile Patient: Considerations in the Management of Invasive Mould Infections (IMIs) in India
por: Kundu, Prithwijit, et al.
Publicado: (2023)

Seroprevalence of hepatitis B virus infection in Cameroon: a systematic review and meta-analysis
por: Bigna, Jean Joel, et al.
Publicado: (2017)

Coming Events
Publicado: (1899)

Unravelling the history of hepatitis B virus genotypes A and D infection using a full-genome phylogenetic and phylogeographic approach
por: Kostaki, Evangelia-Georgia, et al.
Publicado: (2018)

Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study
por: Jiang, Ivy, et al.
Publicado: (2021)

Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases
por: Mougui, Ahmed, et al.
Publicado: (2023)

Possible Links between Intestinal Permeablity and Food Processing: A Potential Therapeutic Niche for Glutamine
por: Rapin, Jean Robert, et al.
Publicado: (2010)

Inequity and vulnerability in Latin American Indigenous and non-Indigenous populations with rheumatic diseases: a syndemic approach
por: Granados, Ysabel, et al.
Publicado: (2023)

Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study
por: Kringelbach, Tina Marie, et al.
Publicado: (2018)

Psychometric evaluation of the Arthritis Self-Efficacy Scale in Chinese adults with rheumatic diseases: a cross-sectional study
por: Tsai, Tzung-Yi, et al.
Publicado: (2021)

NET-RMDs study: networks of fatigue and pain in rheumatic and musculoskeletal diseases – protocol for an international cross-sectional study
por: Gavilán-Carrera, Blanca, et al.
Publicado: (2022)

Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern Bulgaria
por: Brady, Zarina, et al.
Publicado: (2019)

Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study
por: Chen, Sarah K, et al.
Publicado: (2019)

Gout Treatment and Clinical Considerations: The Role of Pegloticase, Colchicine, and Febuxostat
por: Quintana, Michael J, et al.
Publicado: (2023)

Hand-related physical function in rheumatic hand conditions: a protocol for developing a patient-reported outcome measurement instrument
por: Klokker, Louise, et al.
Publicado: (2016)

Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study
por: Smith, Toby O, et al.
Publicado: (2021)

Burden of hepatitis B virus and syphilis co-infections and its impact on HIV treatment outcome in Ethiopia: nationwide community-based study
por: Getaneh, Yimam, et al.
Publicado: (2023)

Prevalence of undiagnosed HIV, hepatitis B, and hepatitis C among patients in an Indian emergency department
por: Pandiselvam, Sathishkumar, et al.
Publicado: (2020)

Children's Food and Management
Publicado: (1886)

Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study
por: Alvarez-Madrazo, Samantha, et al.
Publicado: (2019)

Post-traumatic stress disorder in patients with rheumatic disease during the COVID-19 outbreak: a cross-sectional case–control study in China
por: Wu, Xin, et al.
Publicado: (2022)

Treatment as prevention for hepatitis C virus in Pakistan: mathematical modelling projections
por: Ayoub, Houssein H, et al.
Publicado: (2019)

Adequate Knowledge and Low Vaccination Rates of Hepatitis B Virus Infection Among Students, Medical, and Paramedical Persons in a Tertiary Care Teaching Hospital
por: Kandi, Venkataramana, et al.
Publicado: (2020)

Patients’ experiences regarding self-monitoring of the disease course: an observational pilot study in patients with inflammatory rheumatic diseases at a rheumatology outpatient clinic in The Netherlands
por: Renskers, Lisanne, et al.
Publicado: (2020)

Interaction effects among IFN-γ+874, IL-2-330, IL-10-1082, IL-10-592 and IL-4-589 polymorphisms on the clinical progression of subjects infected with hepatitis B virus and/or hepatitis C virus: a retrospective nested case–control study
por: Gao, Qiu-Ju, et al.
Publicado: (2017)

Coronavirus disease 2019: International public health considerations
por: Greene, Christopher J., et al.
Publicado: (2020)

High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda
por: Bayo, Pontius, et al.
Publicado: (2014)

Prevention of mother-to-child transmission of hepatitis B virus: protocol for a one-arm, open-label intervention study to estimate the optimal timing of tenofovir in pregnancy
por: Bierhoff, Marieke, et al.
Publicado: (2020)

A Comparison of the Awareness, Attitude, and Uptake of COVID-19, Hepatitis B Virus, and Yellow Fever Vaccines Between Rural and Urban Respondents in Edo State, Nigeria
por: Osarenkhoe, John O, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5gmkckpdimibqatkcrlmcrr2rc